With CPhI Korea and Milan postponed for 2020. What’s next?

Following the cancellation of 2020 events worldwide, the recent announcements for CPhI events should come as no surprise. Undeterred, organizers are taking bold & creative initiatives to bring people together.

Following talks with stakeholders across the Pharma industry event organizer Informa announced that it wouldn’t be practical to go ahead as planned, and has decided to transform the world’s largest pharma exhibition into a digital event: The CPhI ‘Festival of Pharma’.

Running from 5-16th October, Adam Andersen, Group Director of Pharma at Informa Markets says: “This large-scale digital exhibition will mirror on-site offerings and provide our community with a powerful platform to access vital one-to-one client meetings”.

“This community is resilient.. and we feel compelled to (provide) new and alternative ways to foster connections, discover new partners and help lead the global response and recovery” added Anderson.

QUINTA-ANALYTICA are thrilled to digitally ‘meet’ colleagues from the industry, highlight the world-leading projects we’ve been working on, and of course, to make new connections!

What do you think about the increasing digitization of events? Do you plan to virtually attend any this year?

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.